New drug ISM8969 enters first human safety tests
NCT ID NCT07581431
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This early-stage study tests whether a new oral drug called ISM8969 is safe and how the body processes it. About 100 healthy adults, elderly people, and obese adults at risk for heart disease will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network Pty Ltd.
Melbourne, Victoria, Australia
Conditions
Explore the condition pages connected to this study.